piperazine has been researched along with Pancreatic Neoplasms in 3 studies
Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Akl, L | 1 |
Abd El-Hafeez, AA | 1 |
Ibrahim, TM | 1 |
Salem, R | 1 |
Marzouk, HMM | 1 |
El-Domany, RA | 1 |
Ghosh, P | 1 |
Eldehna, WM | 1 |
Abou-Seri, SM | 1 |
Laskowska, AK | 1 |
Puszko, AK | 1 |
Sosnowski, P | 1 |
Różycki, K | 1 |
Kosson, P | 1 |
Matalińska, J | 1 |
Durlik, M | 1 |
Misicka, A | 1 |
Pati, ML | 1 |
Hornick, JR | 1 |
Niso, M | 1 |
Berardi, F | 1 |
Spitzer, D | 1 |
Abate, C | 1 |
Hawkins, W | 1 |
3 other studies available for piperazine and Pancreatic Neoplasms
Article | Year |
---|---|
Identification of novel piperazine-tethered phthalazines as selective CDK1 inhibitors endowed with in vitro anticancer activity toward the pancreatic cancer.
Topics: Antineoplastic Agents; Carcinoma, Pancreatic Ductal; CDC2 Protein Kinase; Cell Line, Tumor; Cell Pro | 2022 |
Identification of novel piperazine-tethered phthalazines as selective CDK1 inhibitors endowed with in vitro anticancer activity toward the pancreatic cancer.
Topics: Antineoplastic Agents; Carcinoma, Pancreatic Ductal; CDC2 Protein Kinase; Cell Line, Tumor; Cell Pro | 2022 |
Identification of novel piperazine-tethered phthalazines as selective CDK1 inhibitors endowed with in vitro anticancer activity toward the pancreatic cancer.
Topics: Antineoplastic Agents; Carcinoma, Pancreatic Ductal; CDC2 Protein Kinase; Cell Line, Tumor; Cell Pro | 2022 |
Identification of novel piperazine-tethered phthalazines as selective CDK1 inhibitors endowed with in vitro anticancer activity toward the pancreatic cancer.
Topics: Antineoplastic Agents; Carcinoma, Pancreatic Ductal; CDC2 Protein Kinase; Cell Line, Tumor; Cell Pro | 2022 |
Opioid Tripeptides Hybridized with trans-1-Cinnamylpiperazine as Proliferation Inhibitors of Pancreatic Cancer Cells in Two- and Three-Dimensional in vitro Models.
Topics: Amino Acid Sequence; Analgesics, Opioid; Cell Culture Techniques; Cell Line; Cell Proliferation; Cel | 2017 |
Sigma-2 receptor agonist derivatives of 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) induce cell death via mitochondrial superoxide production and caspase activation in pancreatic cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Death; Cell Line, Tumor; Cell Proliferati | 2017 |